235 related articles for article (PubMed ID: 22753445)
1. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
Jankovic J; Schwartz K; Clemence W; Aswad A; Mordaunt J
Mov Disord; 1996 May; 11(3):250-6. PubMed ID: 8723140
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of botulinum toxin in primary orthostatic tremor.
Bertram K; Sirisena D; Cowey M; Hill A; Williams DR
J Clin Neurosci; 2013 Nov; 20(11):1503-5. PubMed ID: 23931935
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for treating voice tremor.
Adler CH; Bansberg SF; Hentz JG; Ramig LO; Buder EH; Witt K; Edwards BW; Krein-Jones K; Caviness JN
Arch Neurol; 2004 Sep; 61(9):1416-20. PubMed ID: 15364688
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
8. Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines.
Glogau R; Blitzer A; Brandt F; Kane M; Monheit GD; Waugh JM
J Drugs Dermatol; 2012 Jan; 11(1):38-45. PubMed ID: 22206075
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.
Díaz-Llopis IV; Rodríguez-Ruíz CM; Mulet-Perry S; Mondéjar-Gómez FJ; Climent-Barberá JM; Cholbi-Llobel F
Clin Rehabil; 2012 Jul; 26(7):594-606. PubMed ID: 22144721
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
12. Facing depression with botulinum toxin: a randomized controlled trial.
Wollmer MA; de Boer C; Kalak N; Beck J; Götz T; Schmidt T; Hodzic M; Bayer U; Kollmann T; Kollewe K; Sönmez D; Duntsch K; Haug MD; Schedlowski M; Hatzinger M; Dressler D; Brand S; Holsboer-Trachsler E; Kruger TH
J Psychiatr Res; 2012 May; 46(5):574-81. PubMed ID: 22364892
[TBL] [Abstract][Full Text] [Related]
13. Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach.
Mittal SO; Machado D; Richardson D; Dubey D; Jabbari B
Mayo Clin Proc; 2017 Sep; 92(9):1359-1367. PubMed ID: 28789780
[TBL] [Abstract][Full Text] [Related]
14. Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size.
Cousins E; Ward A; Roffe C; Rimington L; Pandyan A
Clin Rehabil; 2010 Jun; 24(6):501-13. PubMed ID: 20483887
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial.
Dowson C; Sahai A; Watkins J; Dasgupta P; Khan MS
Int J Clin Pract; 2011 Jun; 65(6):698-704. PubMed ID: 21564444
[TBL] [Abstract][Full Text] [Related]
16. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.
Schnider P; Binder M; Auff E; Kittler H; Berger T; Wolff K
Br J Dermatol; 1997 Apr; 136(4):548-52. PubMed ID: 9155956
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
Sahai A; Khan MS; Dasgupta P
J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
[TBL] [Abstract][Full Text] [Related]
18. Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
Marques A; Pereira B; Simonetta-Moreau M; Castelnovo G; De Verdal M; Fluchère F; Laurencin C; Degos B; Tir M; Kreisler A; Blanchet-Fourcade G; Guehl D; Colin O; Poujois A; Sangla S; Tatu L; Derost P; Gayraud D; Tranchant C; Amarantini D; Devos D; Rascol O; Corvol JC; Durif F; Rieu I;
N Engl J Med; 2023 Nov; 389(19):1753-1765. PubMed ID: 37937777
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
